Cas:84163-13-3 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride manufacturer & supplier

Chemical Name:6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride

CAS.NO:84163-13-3

Synonyms:6-Fluor-3-(piperidin-4-yl)-1,2-benzisoxazolhydrochlorid;6-Fluoro-3-(piperidin-4-yl)-1,2-benzoxazole hydrochloride (1:1);6-Fluoro-3-(4-piperidinyl)-1,2-benzoxazole hydrochloride;6-fluoro-3-piperidin-4-yl-1,2-benzoxazole,hydrochloride;6-Fluoro-3-(4-piperidinyl)-1,2-benzoxazole hydrochloride (1:1);6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride;6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole hydrochloride;1,2-Benzisoxazole, 6-fluoro-3-(4-piperidinyl)-, hydrochloride (1:1);6-Fluoro-3-(piperidin-4-yl)-1,2-benzisoxazole hydrochloride;MFCD03236724

Molecular Formula:C₁₂H₁₄ClFN₂O

Molecular Weight:256.704

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:387.3ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:38.06000

Exact Mass:256.077881

LogP:3.56470

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 6-Fluor-3-(piperidin-4-yl)-1,2-benzisoxazolhydrochlorid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD03236724 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-fluoro-3-(piperidin-4-yl)-1,2-benzoxazole hydrochloride Use and application,6-Fluoro-3-(piperidin-4-yl)-1,2-benzoxazole hydrochloride (1:1) technical grade,usp/ep/jp grade.

Related News: FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride manufacturer South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak. 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride supplier ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride vendor The workers are demanding that Hong Kong close all border checkpoints to visitors from mainland China, saying they represent a threat to health care workers in the city. 6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride factory South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak.